Conatus Pharmaceuticals (CNAT) null Earnings

6NovConfirmed
Mar 19
May 19
Aug 19
Nov 19
-0.14
-0.1
-0.06
-0.02

Details

Expected EPS
-0.12
Actual EPS
-0.1
Surprise EPS
0.02
Surprise Percent
+16.67%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.1 per share for .

0 Comments

Share your thoughts